NCT00710697View on ClinicalTrials.gov

Cardiac Safety Assessment Study of Picoplatin in Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2009

Conditions
Solid Tumors
Interventions
DRUG

Picoplatin

IV 150 mg/m2, IV (in the vein) on day 1 of each 21 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.

Trial Locations (7)

30341

Georgia Cancer Specialists, Atlanta

85258

Premiere Oncology of Arizona, Scottsdale

87131

UNM Cancer Center, Albuquerque

90404

Premiere Oncology, Santa Monica

92093

Moores UCSD Cancer Center, La Jolla

98104

Swedish Cancer Institute, Seattle

98405

Northwest Medical Specialities, Tacoma

Sponsors
All Listed Sponsors
lead

Poniard Pharmaceuticals

INDUSTRY